Triptans vs other drugs for acute migraine. Are there differences in efficacy? A comment

Headache

Volumn 48, Issue 4, 2008, Pages 601-605

  Tfelt Hansen, Peer ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Aspirin; Migraine; Triptans

Indexed keywords

ACETYLSALICYLIC ACID; ALMOTRIPTAN; CAFFEINE; DICLOFENAC; DIHYDROERGOTAMINE; ELETRIPTAN; ERGOTAMINE; IBUPROFEN; INDOMETACIN; KETOPROFEN; METOCLOPRAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROCHLORPERAZINE; RIZATRIPTAN; SUMATRIPTAN; TOLFENAMIC ACID; TRIPTAN DERIVATIVE; ZOLMITRIPTAN;

CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; DISEASE SEVERITY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG COST; DRUG DOSAGE FORM; DRUG EFFICACY; HUMAN; MIGRAINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE;

ANALGESICS; HUMANS; MIGRAINE DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRYPTAMINES;

EID: 41549108103     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2008.01064.x     Document Type: Review

References (35)

1. Humphrey PP. The discovery of a new drug class for the acute treatment of migraine. Headache. 2007 47 (Suppl 1 S10 S19.
2. Tfelt-Hansen P, De Vries P, Saxena PR. Triptans in migraine. A comparative review of pharmacology, pharmacokinetics and efficacy. Drugs. 2000 60 : 1259 1287.
3. Saxena PR, Tfelt-Hansen P. Triptans, HT1B/1D agonists in the acute treatment of migraine. In : Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA, eds. The Headaches, 3rd edn. Philadelphia, PA : Lippincott Williams & Wilkins 2006 : 469 503.
4. Goadsby PJ. Recent advances in understanding migraine mechanisms, molecules and therapeutics. Trends Mol Med. 2007 13 : 39 44.
5. 1B/1D agonists) in acute migraine: A meta-analysis of 53 trials. Lancet. 2001 358 : 1668 1675.
6. 1B/1D agonists) in migraine: Detailed results and methods of a meta-analysis of 53 trials. Cephalalalgia. 2002 22 : 633 658.
7. Helfand M, Peterson K. Drug Class Review on Triptans: Final Report Update 3. Portland, OR: Oregon Health & Science University; 2005. Available at: http://www.ohsu.edu/drugeffectiveness/reports/documents/ Triptans%20Final%20Report%20Update%2034.pdf. Accessed December 2007.
8. Lipton RB, Bigal ME, Lieberman JN, et al. Migraine practice among neurologists. Neurology. 2004 62 : 1226 1231.
9. Lipton RB, Bigal ME, Goadsby PJ. Double-blind clinical trials of oral triptans vs other classes of acute migraine medications - A review. Cephalalgia. 2004 24 : 321 332.
10. Membe S, McGahan L, Cimon K, Gawel M, Giammarco R, Mierzwinski-Urban M. Triptans for Acute Migraine: Comparative Clinical Effectiveness and Cost-Effectivenes Technology report no 76. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2007. Available at: http://www.cadth.ca. Accessed December 2007.
11. International Headache Society Clinical Trial Subcommittee. Guidelines for controlled trials of drugs in migraine, 2nd edition. Cephalalgia. 2000 20 : 765 786.
12. Tfelt-Hansen P, Saxena PR, Dahlof C, et al. Ergotamine in the acute treatment of migraine-European Consensus. Brain. 2000 123 : 9 18.
13. The Multinational Oral Sumatriptan and Cafergot Comparative Study Group. A randomized, double-blind comparison of sumatriptan in the acute treatment of migraine. Eur Neurol. 1991 31 : 314 322.
14. Christie S, Gobel H, Mateos V, Allen C, Vrijens F, Shivaprakash M, Rizatriptan-Ergotamine/Caffeine Preference Study Group. Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine. Eur Neurol. 2003 49 : 20 29.
15. Diener HC, Jansen JP, Reches A, Pascual J, Pitei D, Steiner TJ, Eletriptan and Cafergot Comparative Study Group. Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: A multicentre, randomized, double-blind, placebo-controlled comparison. Eur Neurol. 2002 47 : 99 107.
16. Lainez MJ, Galvan J, Heras J, Vila C. Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migrainde therapy. Eur J Neurol. 2007 14 : 269 275.
17. Ibraheem JJ, Paalzow L, Tfelt-Hansen P. Low bioavailability of ergotamine tartrate after oral and rectal administration in migraine patients. Br J Clin Pharmacol. 1983 16 : 695 699.
18. Ibraheem JJ, Paalzow L, Tfelt-Hansen P. Kinetics of ergotamine after intravenous and intramuscular administration to migraine sufferers. Eur J Clin Pharmacol. 1982 23 : 235 240.
19. Sanders SW, Haering N, Mosberg H, Jaeger H. Pharmacokinetics of ergotamine in healthy volunteers following oral and rectal dosing. Eur J Clin Pharmacol. 1986 30 : 331 334.
20. Tfelt-Hansen P, Saxena PR. Ergot alkaloids in the acute treatment of migraine. In : Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA, eds. The Headaches, 3rd edn. Philadelphia, PA : Lippincott Williams & Wilkins 2006 : 459 467.
21. Diener HC, for the ASASUMAMIG Study Group. Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter parallel group study. Cephalalgia. 1999 19 : 581 588.
22. Tfelt-Hansen P. Parenteral versus oral sumatriptan and naratriptan: Plasma levels and efficacy in migraine. A comment. J Headache Pain. 2007 : 273 276.
23. The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group. A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. Eur Neurol. 1992 32 : 177 184.
24. Tfelt-Hansen P, Henry P, Mulder K, Scheldewaert RG, Schoenen J, Chazot G. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine. Lancet. 1995 346 : 923 926.
25. Diener HC, Bussone G, de Liano H, et al, EMSASI Study Group. Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks. Cephalalgia. 2004 24 : 947 954.
26. Diener HC, Eikerman A, Gessner U, et al. Efficacy of 1000 mg effervescent acetylsalicylic acid and sumatriptan in treating associated migraine symptoms. Eur Neurol. 2004 52 : 50 56.
27. Dib M, Masiou H, Weber M, Henry H, Garcia-Acosta S, Bousser M-G, Bi-Profenid Migraine Study Group. Efficacy of oral ketoprofen in acute migraine: A double-blind randomized trial. Neurology. 2002 58 : 1660 1665.
28. Geraud G, Compagnon A, Rossi A, COZAM Study Group. Zolmitriptan versus a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: A double-blind, randomised, three-attack study. Eur Neurol. 2002 47 : 88 98.
29. The Diclofenac-K/Sumatriptan Study Group. Acute treatment of migraine attacks: Efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. Cephalalgia. 1999 19 : 232 240.
30. Sandrini G, Cerbo R, Del Bene E, et al. Efficacy of dosing and re-dosing of two oral combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: A double-blind, double-dummy, randomised, parallel, multicentre study. Int J Clin Pract. 2007 61 : 1256 1269.
31. Di Monda V, Nicolodi M, Aloisio A, et al. Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine versus sumatriptan in acute treatment of multiple migraine attacks: A multicenter, randomized, crossover trial. Headache. 2003 43 : 835 844.
32. Myllylä VV, Havanka H, Herrala L, et al. Tolfenamic acid rapid release versus sumatriptan in the acute treatment of migraine: Comparable effect in a double-blind, randomized, controlled, parallel-group study. Headache. 1998 38 : 201 207.
33. Tfelt-Hansen P. Triptans vs. other classes of migraine medication. Cephalalgia. 2006 26 : 628.
34. Tfelt-Hansen P, Young WB, Silberstein SD. Antiemetics, prokinetics, neuroleptic and miscellaneous drugs in the acute treatment of migraine. In : Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA, eds. The Headaches, 3rd edn. Philadelphia, PA : Lippincott Williams & Wilkins 2006 : 505 513.
35. Lampl C, Voelker M, Diener HC. Efficacy and safety of 1000 mg effervescent aspirin: Individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms. J Neurol. 2007 254 : 705 712.